US7893101B2
(en)
*
|
2002-03-20 |
2011-02-22 |
Celgene Corporation |
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7135575B2
(en)
*
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
AU2004218463B2
(en)
*
|
2003-03-03 |
2009-07-16 |
Array Biopharma, Inc. |
p38 inhibitors and methods of use thereof
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US8273347B2
(en)
*
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
EP1663237B1
(fr)
*
|
2003-09-10 |
2013-06-19 |
Icagen, Inc. |
Anneaux condenses heterocycliques modulateurs des canaux de potassium
|
WO2005037826A1
(fr)
|
2003-10-17 |
2005-04-28 |
Incyte Corporation |
Inhibiteurs de metalloproteases matrices a base d'hydroxamates cycliques substitues
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
KR101164258B1
(ko)
|
2003-12-23 |
2012-07-11 |
아스텍스 테라퓨틱스 리미티드 |
단백질 키나아제 조절제로서의 피라졸 유도체
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
MXPA06009462A
(es)
*
|
2004-02-27 |
2007-03-15 |
Hoffmann La Roche |
Derivados pirazolo heteroaril fusionados.
|
AU2005219518A1
(en)
|
2004-02-27 |
2005-09-15 |
F. Hoffmann-La Roche Ag |
Indazole derivatives and pharmaceutical compositions containing them
|
KR100843526B1
(ko)
*
|
2004-02-27 |
2008-07-03 |
에프. 호프만-라 로슈 아게 |
피라졸의 접합 유도체
|
ES2475207T3
(es)
|
2004-07-15 |
2014-07-10 |
Tetralogic Pharmaceuticals Corporation |
Compuestos de unión a IAP
|
NZ552868A
(en)
*
|
2004-08-12 |
2009-07-31 |
Pfizer |
Triazolopyridinylsulfanyl derivatives as P38 MAP kinase inhibitors
|
EP1647549A1
(fr)
*
|
2004-10-14 |
2006-04-19 |
Laboratoire Theramex |
Indazoles, benzisoxazoles et benzisothiazoles en tant qu'agents oestrogéniques
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
CN103083644B
(zh)
|
2005-02-25 |
2014-05-28 |
泰特拉洛吉克药业公司 |
Iap二聚体抑制剂
|
WO2006103568A2
(fr)
*
|
2005-03-22 |
2006-10-05 |
Innate Pharma |
Nouvelle classe d'activateurs de cellules g? t et utilisation correspondante
|
WO2006123182A2
(fr)
*
|
2005-05-17 |
2006-11-23 |
Merck Sharp & Dohme Limited |
Sulfones de cyclohexyle pour le traitement du cancer
|
US20090232879A1
(en)
|
2005-05-26 |
2009-09-17 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the Treatment of Fatty Liver Diseases
|
WO2006136821A1
(fr)
*
|
2005-06-22 |
2006-12-28 |
Astex Therapeutics Limited |
Composes pharmaceutiques
|
US8541461B2
(en)
*
|
2005-06-23 |
2013-09-24 |
Astex Therapeutics Limited |
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
|
ITRM20050344A1
(it)
*
|
2005-06-30 |
2007-01-01 |
Luca Maria De |
Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
KR20080053297A
(ko)
|
2005-08-11 |
2008-06-12 |
버텍스 파마슈티칼스 인코포레이티드 |
낭포성 섬유종 트랜스막 전도도 조정자의 조절자
|
KR20080039438A
(ko)
*
|
2005-08-25 |
2008-05-07 |
에프. 호프만-라 로슈 아게 |
P38 mαp 키나아제 저해제 및 이의 사용 방법
|
CN101243088B
(zh)
*
|
2005-08-25 |
2011-06-29 |
霍夫曼-拉罗奇有限公司 |
p38 MAP激酶抑制剂及使用它的方法
|
AU2006289751A1
(en)
*
|
2005-09-14 |
2007-03-22 |
Santen Pharmaceutical Co., Ltd. |
Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
|
US7915286B2
(en)
|
2005-09-16 |
2011-03-29 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
EP1931668A2
(fr)
*
|
2005-09-16 |
2008-06-18 |
Ranbaxy Laboratories Limited |
Pyrazolo[3,4-b]pyridines substituées en tant qu'inhibiteurs de la phosphodiesterase
|
WO2007047474A2
(fr)
*
|
2005-10-12 |
2007-04-26 |
Vertex Pharmaceuticals Incorporated |
Derives de biphenyle utilises comme modulateurs des canaux ioniques sensibles au voltage
|
WO2007047397A2
(fr)
*
|
2005-10-13 |
2007-04-26 |
Smithkline Beecham Corporation |
Nouveaux composes heterocycliques
|
US8648087B2
(en)
|
2005-11-15 |
2014-02-11 |
Array Biopharma, Inc. |
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
|
UA94921C2
(en)
*
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
CN101421269A
(zh)
*
|
2006-01-13 |
2009-04-29 |
环状药物公司 |
酪氨酸激酶抑制剂及其用途
|
SG175599A1
(en)
*
|
2006-01-31 |
2011-11-28 |
Array Biopharma Inc |
Kinase inhibitors and methods of use thereof
|
US8541406B2
(en)
*
|
2006-02-07 |
2013-09-24 |
Nv Remynd |
Thiadiazole derivatives for the treatment of neurodegenerative diseases
|
EP1852108A1
(fr)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Compositions d'inhibiteurs de la DPP IV
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
CN102838599A
(zh)
|
2006-05-04 |
2012-12-26 |
贝林格尔.英格海姆国际有限公司 |
多晶型
|
WO2008005651A2
(fr)
*
|
2006-06-08 |
2008-01-10 |
Decode Chemistry, Inc. |
Dérivés d'acide rhodanine-carboxylique cycliques destinés au traitement et à la prévention de la tuberculose
|
US7727978B2
(en)
*
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
WO2008032164A2
(fr)
*
|
2006-09-12 |
2008-03-20 |
Pfizer Products Inc. |
Dérivés de benzimidazolone
|
PL2559689T3
(pl)
|
2006-09-25 |
2018-04-30 |
Ptc Therapeutics, Inc. |
Sposób wytwarzania postaci krystalicznych kwasu 3-[5-(2-fluorofenylo)[1,2,4]oksadiazol-3-ilo]benzoesowego
|
KR20090086539A
(ko)
|
2006-11-14 |
2009-08-13 |
산텐 세이야꾸 가부시키가이샤 |
(치환 페닐 또는 치환 복소환) 카르보닐옥시 저급 알킬기와 에스테르 구조를 도입한 페닐기를 치환기로서 갖는 신규 1,2-디히드로퀴놀린 유도체
|
TW200831085A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
CA2676437A1
(fr)
*
|
2007-01-18 |
2008-07-24 |
Evolva Sa |
1,3-dioxanes substitues et leurs utilisations
|
DE102007009494A1
(de)
*
|
2007-02-27 |
2008-08-28 |
Bayer Healthcare Ag |
Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
|
KR20090117950A
(ko)
|
2007-03-08 |
2009-11-16 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절자 및 그것의 사용 방법
|
US8030344B2
(en)
*
|
2007-03-13 |
2011-10-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
JP5538907B2
(ja)
*
|
2007-03-23 |
2014-07-02 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
セロトニン5−ht6受容体の調節に応答する障害を治療する上で好適なキノリン化合物
|
EP2952186A1
(fr)
*
|
2007-03-26 |
2015-12-09 |
University Of Southern California |
Compositions permettant d'induire l'apoptose en stimulant un stress ER
|
RU2470636C2
(ru)
*
|
2007-04-27 |
2012-12-27 |
Сайдекс Фамэсьютиклз, Инк. |
Композиция клопидогреля и сульфоалкилового эфира циклодекстрина (варианты) и способы лечения заболеваний посредством названной композиции (варианты)
|
EP2011786A1
(fr)
*
|
2007-07-05 |
2009-01-07 |
Laboratorios del Dr. Esteve S.A. |
Dérivés d'indanamine, leur préparation et utilisation en tant que médicaments
|
DE102007032347A1
(de)
*
|
2007-07-11 |
2009-01-15 |
Bayer Healthcare Ag |
Aminoacyl-Prodrugs
|
WO2009015000A1
(fr)
*
|
2007-07-25 |
2009-01-29 |
Array Biopharma Inc. |
Dérivés de pyrazole urée utilisés comme inhibiteurs de kinase
|
TW200908984A
(en)
*
|
2007-08-07 |
2009-03-01 |
Piramal Life Sciences Ltd |
Pyridyl derivatives, their preparation and use
|
WO2009053999A2
(fr)
*
|
2007-08-07 |
2009-04-30 |
Cadila Healthcare Limited |
Dérivés de sulfoximine utilisés en tant qu'inhibiteurs du facteur xa
|
US20110118274A1
(en)
*
|
2007-08-23 |
2011-05-19 |
Cornell Research Foundation, Inc. |
Proteasome inhibitors and their use in treating pathogen infection and cancer
|
US20100292292A1
(en)
*
|
2007-09-13 |
2010-11-18 |
Link Medicine Corporation |
Treatment of Neurodegenerative Diseases Using Indatraline Analogs
|
US10426750B1
(en)
|
2007-09-18 |
2019-10-01 |
Thermolife International, Llc |
Amino acid supplement formulations
|
US8466187B2
(en)
|
2007-09-18 |
2013-06-18 |
Thermolife International, Llc |
Amino acid compositions
|
US10435356B1
(en)
|
2007-09-18 |
2019-10-08 |
Thermolife International, Llc |
Amino acid compositions
|
US10646508B1
(en)
*
|
2007-09-18 |
2020-05-12 |
Thermolife International, Llc |
Method of safely administering nitrate dietary supplements and compositions
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
FR2924712B1
(fr)
*
|
2007-12-06 |
2012-12-21 |
Univ Maine |
Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
|
EP2070929A1
(fr)
|
2007-12-11 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Composés d'alkynylaryle et sels correspondants, compositions pharmaceutiques contenant ceux-ci, procédés de préparation de ceux-ci et usage de ceux-ci
|
AR069650A1
(es)
*
|
2007-12-14 |
2010-02-10 |
Actelion Pharmaceuticals Ltd |
Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
EP2257171B1
(fr)
*
|
2008-02-25 |
2016-02-10 |
Merck Sharp & Dohme Corp. |
Pyridones fusionnés à tétrahydro-1h-pyrrolo
|
US20110003809A1
(en)
*
|
2008-02-29 |
2011-01-06 |
Array Biopharma Inc. |
Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
|
EP2105164B1
(fr)
*
|
2008-03-25 |
2011-01-12 |
Affectis Pharmaceuticals AG |
Nouveaux antagonistes P2X7R et leur utilisation
|
US20090246234A1
(en)
*
|
2008-04-01 |
2009-10-01 |
Benjamin Johnson |
Therapeutic Treatment Using Niacin for Skin Disorders
|
PE20140960A1
(es)
|
2008-04-03 |
2014-08-15 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
EP2116539A1
(fr)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles en tant que ligands améliorant les effets analgésiques des opioïdes et réduisant leur dépendance
|
WO2009144009A1
(fr)
*
|
2008-05-26 |
2009-12-03 |
Medizinische Universität Innsbruck |
Intervention médicale dans des cancers hématologiques
|
GEP20135847B
(en)
|
2008-06-17 |
2013-06-10 |
Millennium Pharm Inc |
Boronate ester compounds and pharmaceutical compositions containing them
|
EP2308842B1
(fr)
*
|
2008-06-25 |
2013-10-23 |
Keio University |
DTCM glutarimide C-12 en tant qu'inhibiteur de iNOS et COX-2
|
EP2313372B1
(fr)
*
|
2008-08-06 |
2013-04-10 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs d aminopyridine kinase
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
WO2010028175A1
(fr)
|
2008-09-08 |
2010-03-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulateurs de l'activité de l'aldéhyde déshydrogénase et leurs procédés d'utilisation
|
AU2009290911A1
(en)
|
2008-09-10 |
2010-03-18 |
Boehringer Ingelheim International Gmbh |
Combination therapy for the treatment of diabetes and related conditions
|
KR100905419B1
(ko)
*
|
2008-09-11 |
2009-07-02 |
연세대학교 산학협력단 |
세스퀴테르펜 유도체의 용도
|
AU2009299927B2
(en)
*
|
2008-10-01 |
2013-05-30 |
Novartis Ag |
Smoothened antagonism for the treatment of hedgehog pathway-related disorders
|
CN102176906B
(zh)
*
|
2008-10-09 |
2014-07-02 |
新树株式会社 |
Panduratin衍生物或提琴形凹唇姜提取物的全新用途
|
AR074797A1
(es)
*
|
2008-10-10 |
2011-02-16 |
Japan Tobacco Inc |
Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
KR20110082180A
(ko)
*
|
2008-10-28 |
2011-07-18 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
알데히드 탈수소효소의 조절자 및 그것의 사용방법
|
DE102008059133A1
(de)
*
|
2008-11-26 |
2010-05-27 |
Merck Patent Gmbh |
Difluorphenyl-diacylhydrazid-derivate
|
KR20100060189A
(ko)
*
|
2008-11-27 |
2010-06-07 |
국립암센터 |
에타크리닉 산을 포함하는 트란스글루타미나제 관련 질환 예방 또는 치료용 조성물 및 그를 이용하는 트란스글루타미나제 관련 질환 예방 또는 치료 방법
|
US8362080B2
(en)
*
|
2008-12-18 |
2013-01-29 |
Baylor College Of Medicine |
Increasing glutathione levels for therapy
|
TWI432188B
(zh)
*
|
2008-12-19 |
2014-04-01 |
Merz Pharma Gmbh & Co Kgaa |
供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
|
AU2009331471B2
(en)
|
2008-12-23 |
2015-09-03 |
Boehringer Ingelheim International Gmbh |
Salt forms of organic compound
|
AR074990A1
(es)
|
2009-01-07 |
2011-03-02 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
|
US9006288B2
(en)
|
2009-01-12 |
2015-04-14 |
Biokier, Inc. |
Composition and method for treatment of diabetes
|
US9314444B2
(en)
*
|
2009-01-12 |
2016-04-19 |
Biokier, Inc. |
Composition and method for treatment of NASH
|
EP2376077B1
(fr)
*
|
2009-01-12 |
2017-03-15 |
Biokier Inc. |
Composition et méthode pour le traitement du diabète
|
WO2010081488A1
(fr)
*
|
2009-01-15 |
2010-07-22 |
Humanitas Mirasole S.P.A. |
Composés dérivés de furoxane libérant de l'oxyde nitrique dotés d'une activité antitumorale
|
EP2389362B1
(fr)
|
2009-01-21 |
2019-12-11 |
Oryzon Genomics, S.A. |
Dérivés de phénylcyclopropylamine et leur utilisation médicale
|
US20100204329A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Mcfaul William J |
Method of using and establishing an absorption rate level and a neuron firing level
|
WO2010093601A1
(fr)
*
|
2009-02-10 |
2010-08-19 |
Metabasis Therapeutics, Inc. |
Nouveaux thyromimetiques contenant de l'acide sulfonique et methodes d'utilisation associees
|
ES2345241B1
(es)
|
2009-03-16 |
2011-09-08 |
Lipopharma Therapeutics |
Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
|
AU2010229144B2
(en)
*
|
2009-03-23 |
2012-07-12 |
Merck Sharp & Dohme Corp. |
P2X3, receptor antagonists for treatment of pain
|
US8946204B2
(en)
|
2009-05-07 |
2015-02-03 |
Gruenenthal Gmbh |
Substituted phenylureas and phenylamides as vanilloid receptor ligands
|
AU2010244685B2
(en)
*
|
2009-05-07 |
2016-02-18 |
Medifron Dbt Inc. |
Substituted phenylureas and phenylamides as vanilloid receptor ligands
|
PT3100728T
(pt)
|
2009-05-13 |
2020-02-21 |
Cydex Pharmaceuticals Inc |
Composições farmacêuticas que compreendem prasugrel e derivados da ciclodextrina e métodos de produção e utilização dos mesmos
|
ES2524361T3
(es)
*
|
2009-06-12 |
2014-12-05 |
United Therapeutics Corporation |
Iminoazúcares para su uso en el tratamiento de enfermedades por bunyavirus y togavirus
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
AU2010289143A1
(en)
*
|
2009-08-24 |
2012-02-16 |
Ascepion Pharmaceuticals, Inc. |
5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
|
WO2011032320A1
(fr)
*
|
2009-09-21 |
2011-03-24 |
F. Hoffmann-La Roche Ag |
Nouveaux dérivés alcényliques d'oxoindole
|
JP2013505290A
(ja)
*
|
2009-09-23 |
2013-02-14 |
ファイザー・インク |
Gpr119調節因子
|
KR101736218B1
(ko)
|
2009-09-25 |
2017-05-16 |
오리존 지노믹스 에스.에이. |
라이신 특이적 디메틸라아제-1 억제제 및 이의 용도
|
EP2486002B1
(fr)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Acétamides d'hétéroaryl- et aryl-cyclopropylamine substitués et leur utilisation
|
KR102668834B1
(ko)
|
2009-11-27 |
2024-05-24 |
베링거 인겔하임 인터내셔날 게엠베하 |
리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
|
EP2528601A1
(fr)
*
|
2010-01-26 |
2012-12-05 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions et procédés pour la prévention et le traitement de l'hypertension pulmonaire
|
US8563610B2
(en)
*
|
2010-02-04 |
2013-10-22 |
Rutgers, The State of New Jersey |
Polyunsaturated fatty acids interactions and oxidative stress disorders
|
EP2353591A1
(fr)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Ligands sigma pour la potentialisation de l'effet analgésique d'opioïdes et d'opiacés dans la douleur post-opératoire et en atténuant la dépendance
|
AU2011215645A1
(en)
|
2010-02-11 |
2012-09-20 |
Vanderbilt University |
Benzisoxazoles and azabenzisoxazoles as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
US9006218B2
(en)
|
2010-02-12 |
2015-04-14 |
Chimerix Inc. |
Nucleoside phosphonate salts
|
WO2011106573A2
(fr)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibiteurs de la lysine déméthylase utilisés dans le traitement et la prévention de maladies et de troubles associés à hepadnaviridae
|
WO2011106105A2
(fr)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibiteurs destinés à une utilisation antivirale
|
KR101876693B1
(ko)
*
|
2010-03-08 |
2018-07-09 |
스펙트럼 파마슈티컬즈 인크 |
암을 치료하기 위한 티옥산톤계 자가포식작용 저해제 치료제
|
ES2607081T3
(es)
*
|
2010-04-19 |
2017-03-29 |
Oryzon Genomics, S.A. |
Inhibidores de desmetilasa específica de lisina-1 y su uso
|
US20130231360A1
(en)
*
|
2010-04-22 |
2013-09-05 |
The Brigham And Women S Hospital, Inc. |
Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases
|
AU2011248620B2
(en)
|
2010-04-26 |
2015-11-26 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
EP2563143A4
(fr)
*
|
2010-04-29 |
2013-09-25 |
Merck Sharp & Dohme |
1,3-benzothiazol-2(3h)-ones et [1,3]thiazolo[5,4-b]pyridin-2(1h)-ones substituées formant des effecteurs allostériques positifs de mglur2
|
ES2935300T3
(es)
|
2010-05-05 |
2023-03-03 |
Boehringer Ingelheim Int |
Combiterapia
|
GB201008005D0
(en)
*
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
SG10201503504VA
(en)
*
|
2010-05-14 |
2015-06-29 |
Agency Science Tech & Res |
Novel Antimicrobial Compounds And Uses Thereof
|
EP2388005A1
(fr)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Ligands sigma pour la prévention et/ou le traitement du vomissement induit par la chimiothérapie ou la radiothérapie
|
CN102918021B
(zh)
*
|
2010-05-27 |
2015-02-11 |
塔加西普特公司 |
烟碱受体非竞争性拮抗剂
|
GB201010359D0
(en)
*
|
2010-06-21 |
2010-08-04 |
Univ Nottingham |
Compounds for treating proliferative disorders
|
KR20230051307A
(ko)
|
2010-06-24 |
2023-04-17 |
베링거 인겔하임 인터내셔날 게엠베하 |
당뇨병 요법
|
CA2802733C
(fr)
*
|
2010-06-24 |
2017-11-21 |
Alkermes Pharma Ireland Limited |
Promedicaments de composes nh-acides : derives esters, carbonates, carbamates et phosphonates
|
TW201204733A
(en)
*
|
2010-06-25 |
2012-02-01 |
Kowa Co |
Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same
|
US8846671B2
(en)
*
|
2010-07-01 |
2014-09-30 |
Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences |
Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
|
WO2012007416A1
(fr)
*
|
2010-07-13 |
2012-01-19 |
Bayer Pharma Aktiengesellschaft |
Pyrimidines bicycliques
|
ES2539257T3
(es)
|
2010-07-28 |
2015-06-29 |
Bayer Intellectual Property Gmbh |
Imidazo[1,2-b]piridazinas sustituidas
|
ES2592161T3
(es)
*
|
2010-07-29 |
2016-11-28 |
Astellas Pharma Inc. |
Compuestos de piridina condensados como ligandos del receptor cannabinoide CB2
|
HUE037937T2
(hu)
|
2010-07-29 |
2021-11-29 |
Oryzon Genomics Sa |
Arilciklopropilamin-alapú LSD1-demetiláz inhibitorok és gyógyászati alkalmazásuk
|
US9006449B2
(en)
|
2010-07-29 |
2015-04-14 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as LSD1 inhibitors
|
EP2415471A1
(fr)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Utilisation de ligands sigma dans l'hyperalgie induite par opioïdes
|
PL392436A1
(pl)
*
|
2010-09-17 |
2012-03-26 |
Adamed Spółka Z Ograniczoną Odpowiedzialnością |
Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
|
JP2013538784A
(ja)
*
|
2010-10-01 |
2013-10-17 |
ラクオリア創薬株式会社 |
Trpm8拮抗剤としてのスルファモイル安息香酸ヘテロ二環性誘導体
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
EP2630128A4
(fr)
*
|
2010-10-20 |
2013-08-28 |
Biota Scient Management |
Inhibiteurs d'une polymérase virale
|
TWI537258B
(zh)
|
2010-11-05 |
2016-06-11 |
百靈佳殷格翰國際股份有限公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
EA023821B1
(ru)
*
|
2010-11-24 |
2016-07-29 |
Мерк Патент Гмбх |
Хиназолинкарбоксамидазетидины, их применение в лечении гиперпролиферативных заболеваний и содержащие их композиции
|
WO2012072713A2
(fr)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Inhibiteurs de la déméthylase spécifique de la lysine pour des maladies et troubles liés aux flaviviridés
|
US9096504B2
(en)
*
|
2010-12-01 |
2015-08-04 |
Washington State University |
Controlled chemical release of hydrogen sulfide
|
US9480663B2
(en)
|
2011-01-07 |
2016-11-01 |
Elcelyx Therapeutics, Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
MX2013007884A
(es)
*
|
2011-01-07 |
2013-09-13 |
Elcelyx Therapeutics Inc |
Terapias a base de ligando del receptor quimiosensorial.
|
US11974971B2
(en)
|
2011-01-07 |
2024-05-07 |
Anji Pharmaceuticals Inc. |
Compositions and methods for treating metabolic disorders
|
US11759441B2
(en)
|
2011-01-07 |
2023-09-19 |
Anji Pharmaceuticals Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US9211263B2
(en)
|
2012-01-06 |
2015-12-15 |
Elcelyx Therapeutics, Inc. |
Compositions and methods of treating metabolic disorders
|
US9572784B2
(en)
|
2011-01-07 |
2017-02-21 |
Elcelyx Therapeutics, Inc. |
Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
EP2668951B9
(fr)
*
|
2011-01-25 |
2017-03-15 |
Viviabiotech, S.L. |
Dérivés de 1,2,4-oxadiazol utilisés en tant que médicaments modulateurs du récepteur pour le peptide glp-1
|
WO2012107498A1
(fr)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Inhibiteurs de lysine diméthylase pour des troubles myéloprolifératifs
|
US20120208872A1
(en)
*
|
2011-02-11 |
2012-08-16 |
Taipei Medical University |
Use of tea polyphenols for treating and/or preventing nicotine or nicotine-derived compounds or estrogen induced breast cancer
|
MX348131B
(es)
*
|
2011-02-25 |
2017-05-26 |
Merck Sharp & Dohme |
Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos.
|
US8642655B2
(en)
*
|
2011-03-09 |
2014-02-04 |
Benjamin Johnson |
Systems and methods for preventing cancer and treating skin lesions
|
MY161170A
(en)
|
2011-03-18 |
2017-04-14 |
Corcept Therapeutics Inc |
Pyrimidine cyclohexyl glucocorticoid receptor modulators
|
US9018257B2
(en)
*
|
2011-03-24 |
2015-04-28 |
Bar Ilan University |
5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
|
US8791112B2
(en)
*
|
2011-03-30 |
2014-07-29 |
Arrien Pharmaceuticals Llc |
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
|
AU2012242565B2
(en)
|
2011-04-13 |
2017-05-11 |
Thermolife International, Llc |
N-Acetyl Beta Alanine methods of use
|
ES2617215T3
(es)
*
|
2011-04-19 |
2017-06-15 |
Daiichi Sankyo Company, Limited |
Derivado de tetrahirotiazepina
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
EP2524694A1
(fr)
*
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Utilisation de ligands sigma dans la douleur liée au diabète de type 2
|
US8487008B2
(en)
*
|
2011-06-22 |
2013-07-16 |
Universita Degli Studi Di Padova |
Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
|
WO2012177263A1
(fr)
*
|
2011-06-24 |
2012-12-27 |
Intra-Cellular Therapies, Inc. |
Composés et procédés de prophylaxie et de traitement concernant des antagonistes de récepteur nicotinique
|
US8658677B2
(en)
*
|
2011-07-07 |
2014-02-25 |
Aria Neurosciences Inc. |
Pyridyl-2-methylamino compounds, compositions and uses thereof
|
EA030121B1
(ru)
|
2011-07-15 |
2018-06-29 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Замещенные хиназолины, их получение и их применение в фармацевтических композициях
|
TW201311679A
(zh)
*
|
2011-08-04 |
2013-03-16 |
Takeda Pharmaceutical |
含氮雜環化合物
|
UA113291C2
(xx)
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
CA2848726C
(fr)
*
|
2011-08-19 |
2019-09-10 |
Emory University |
Agoniste de bax, compositions et procedes associes
|
AR087841A1
(es)
*
|
2011-09-14 |
2014-04-23 |
Chiesi Farma Spa |
Derivados de tetrahidrotriazolopirimidina
|
EP2755483B1
(fr)
|
2011-09-14 |
2018-11-28 |
Samumed, LLC |
Indazole-3-carboxamides et leur utilisation en tant qu'inhibiteurs de la voie de signalisation par wnt/ -caténine
|
BR112014006788A2
(pt)
|
2011-09-26 |
2017-06-13 |
Gruenenthal Gmbh |
derivados de metanossulfonamida substituídos com arila ou n-heteroarila como ligantes de receptor vaniloide
|
EP2760836A1
(fr)
*
|
2011-09-26 |
2014-08-06 |
Grünenthal GmbH |
Dérivés de méthanesulfonamide à substitution amine en tant que ligands des récepteurs des vanilloïdes
|
EP2768805B1
(fr)
|
2011-10-20 |
2020-03-25 |
Oryzon Genomics, S.A. |
Composés (hétéro)aryl cyclopropyl comme inhibiteurs de lsd1
|
PE20141692A1
(es)
|
2011-10-20 |
2014-11-08 |
Oryzon Genomics Sa |
Compuestos de (hetero) aril ciclopropilamina como inhibidores de lsd1
|
CN104136031B
(zh)
|
2011-10-26 |
2016-05-04 |
凯姆制药公司 |
氢吗啡酮的苯甲酸缀合物、苯甲酸衍生物缀合物和杂芳基羧酸缀合物、其前药、制备和使用方法
|
CA2856235A1
(fr)
*
|
2011-11-13 |
2013-05-16 |
Blanchette Rockefeller Neurosciences Institute |
Esters de dcpla pour le traitement de troubles neurodegeneratifs
|
US9284337B2
(en)
|
2011-11-22 |
2016-03-15 |
Trustees Of Tufts College |
Small molecule enhancer for dendritic cell cancer vaccines
|
WO2013084153A1
(fr)
*
|
2011-12-05 |
2013-06-13 |
Glenmark Pharmaceuticals S.A. |
Composition pharmaceutique comprenant un antagoniste de trpa1 et un agent anticholinergique
|
KR20200137035A
(ko)
|
2012-01-06 |
2020-12-08 |
앤지 파마 유에스 엘엘씨 |
바이구아나이드 조성물 및 대사 장애를 치료하는 방법
|
KR102231554B1
(ko)
|
2012-01-06 |
2021-03-23 |
앤지 파마 유에스 엘엘씨 |
대사 장애를 치료하는 조성물 및 방법
|
CN102603493B
(zh)
*
|
2012-01-17 |
2014-03-12 |
青岛农业大学 |
含氟邻烯丙基苯酚类化合物的制备方法及农用生物活性
|
EP2814471A1
(fr)
*
|
2012-02-14 |
2014-12-24 |
Repros Therapeutics Inc. |
Modulateurs sélectifs des récepteurs d' strogènes à demi-vies courtes et leurs utilisations
|
CN102614177B
(zh)
*
|
2012-03-06 |
2014-08-06 |
北京伟峰益民科技有限公司 |
卢帕他定在制备治疗慢性阻塞性肺病药物组合物中的应用
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
WO2013144080A1
(fr)
*
|
2012-03-30 |
2013-10-03 |
Nestec S.A. |
Acide 4-oxo-2-penténoïque et santé cardiovasculaire
|
US9499484B2
(en)
*
|
2012-04-02 |
2016-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Indole, indoline derivatives, compositions comprising them and uses thereof
|
KR20140144178A
(ko)
*
|
2012-04-04 |
2014-12-18 |
키에시 파르마슈티시 엣스. 피. 에이. |
신경퇴행성 질환의 치료를 위한 1-(2-할로-비페닐-4-일)알칸카복실산의 유도체
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
US8809376B2
(en)
*
|
2012-04-30 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
WO2013171167A1
(fr)
|
2012-05-14 |
2013-11-21 |
Boehringer Ingelheim International Gmbh |
Dérivé de xanthine en tant qu'inhibiteur de dpp-4 pour l'utilisation dans le traitement de troubles associés aux podocytes et/ou un syndrome néphrotique
|
WO2013174767A1
(fr)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
CA2876979A1
(fr)
*
|
2012-06-20 |
2013-12-27 |
P. Jeffrey Conn |
Analogues alcoxy pyrazoles bicycliques substitues en tant que modulateurs allosteriques des recepteurs mglur5
|
US20130345205A1
(en)
*
|
2012-06-20 |
2013-12-26 |
Vanderbilt University |
Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors
|
CA2879431A1
(fr)
|
2012-07-17 |
2014-01-23 |
Washington University |
Medicaments anti-mucus et leurs utilisations
|
ES2941477T3
(es)
|
2012-08-13 |
2023-05-23 |
Univ Rockefeller |
Agonista de LXRbeta para el tratamiento de cáncer
|
WO2014031732A2
(fr)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Méthodes d'inhibition de la fascine
|
AU2013307688A1
(en)
*
|
2012-08-29 |
2015-04-09 |
Merck Patent Gmbh |
Ddr2 inhibitors for the treatment of osteoarthritis
|
US8859598B2
(en)
*
|
2012-10-04 |
2014-10-14 |
Allergan, Inc. |
1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
|
US9278081B2
(en)
*
|
2012-10-04 |
2016-03-08 |
University Of The West Indies |
Extracts from Eucalyptus camaldulensis for the treatment of hyperglycemia and hypertension
|
JP2015535283A
(ja)
|
2012-11-02 |
2015-12-10 |
レプロス セラピューティクス インコーポレイティド |
癌療法における使用のためのトランス−クロミフェン
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
WO2014081878A2
(fr)
|
2012-11-21 |
2014-05-30 |
Stategics, Inc. |
Composés triazolo-pyrimidines substitués pour la modulation de la prolifération, la différentiation et la survie cellulaires
|
CN104822669A
(zh)
*
|
2012-12-05 |
2015-08-05 |
奇斯药制品公司 |
作为pde-4抑制剂的苯基乙基吡啶衍生物
|
WO2014086712A1
(fr)
|
2012-12-07 |
2014-06-12 |
Boehringer Ingelheim International Gmbh |
Nouveaux acides indanyloxydihydrobenzofuranylacétiques
|
UY35212A
(es)
*
|
2012-12-21 |
2014-06-30 |
Gilead Sciences Inc |
Inhibidores de la quinasa que regula la señal de la apoptosis
|
WO2014110086A2
(fr)
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
Inhibiteurs de 3-(benzoimidazol-2-yl)-indazole de la voie de signalisation par wnt et leurs utilisations thérapeutiques
|
CU20130027A7
(es)
*
|
2013-02-28 |
2014-10-30 |
Ct De Neurociencias De Cuba |
Chaperoninas químicas como nuevos moduladores moleculares de la beta agregación proteica presente en las enfermedades conformacionales
|
US9670162B2
(en)
|
2013-03-14 |
2017-06-06 |
The Board Of Trustees Of The Leland Stanford Junio |
Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
|
WO2014153208A1
(fr)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Inhibiteurs d'arginine méthyltransférase et leurs utilisations
|
US9447079B2
(en)
|
2013-03-14 |
2016-09-20 |
Epizyme, Inc. |
PRMT1 inhibitors and uses thereof
|
US9765035B2
(en)
|
2013-03-14 |
2017-09-19 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
RS61231B1
(sr)
|
2013-03-14 |
2021-01-29 |
Epizyme Inc |
Inhibitori arginin-metiltransferaze i njihove upotrebe
|
US9120757B2
(en)
|
2013-03-14 |
2015-09-01 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
EP2970135B1
(fr)
|
2013-03-14 |
2018-07-18 |
Epizyme, Inc. |
Derives de pyrazol comme des inhibiteurs de prmt1 et leur utilisation
|
WO2014153214A1
(fr)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Inhibteurs de l'arginine méthyltransférase et utilisations de ceux-ci
|
US9776972B2
(en)
|
2013-03-14 |
2017-10-03 |
Epizyme Inc. |
Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
|
US9611259B2
(en)
*
|
2013-03-15 |
2017-04-04 |
Janssen Pharmaceutica Nv |
Substituted pyridine derivatives useful as C-FMS kinase inhibitors
|
US20140335079A1
(en)
*
|
2013-05-07 |
2014-11-13 |
Emory University |
Solenopsin and derivatives, therapeutic compositions, and methods related thereto
|
JP5740062B1
(ja)
*
|
2013-07-03 |
2015-06-24 |
三菱化学フーズ株式会社 |
毛状疣贅病の予防および/または治療方法
|
MA38837B1
(fr)
|
2013-07-18 |
2018-10-31 |
Novartis Ag |
Inhibiteurs de l'autotaxine contenant un noyau à cycle benzyle-amide cyclique hétéroaromatique
|
US20150045435A1
(en)
*
|
2013-08-06 |
2015-02-12 |
Indiana University Research And Technology Corporation |
Compounds and methods for treating diabetes
|
US20160199372A1
(en)
*
|
2013-08-20 |
2016-07-14 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
US9926275B2
(en)
*
|
2013-08-22 |
2018-03-27 |
Northeastern University |
Allosteric modulators of the cannabinoid 1 receptor
|
WO2015039029A1
(fr)
|
2013-09-13 |
2015-03-19 |
The Board Of Trustees Of The University Of Arkansas |
Préparation et utilisation d'une composition pour la prévention et l'atténuation des effets de rayonnements
|
US9353078B2
(en)
*
|
2013-10-01 |
2016-05-31 |
New York University |
Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof
|
NZ718817A
(en)
|
2013-10-22 |
2020-07-31 |
Massachusetts Inst Technology |
Lipid formulations for delivery of messenger rna
|
LT3081566T
(lt)
*
|
2013-12-13 |
2018-05-25 |
Daiichi Sankyo Company, Limited |
5-hidroksi-4-(trifluormetil)pirazolpiridino darinys
|
TW201607538A
(zh)
|
2013-12-17 |
2016-03-01 |
以斯提夫博士實驗室股份有限公司 |
血清素-去甲腎上腺素再攝取抑制劑(SNRIS)和σ受體配體組合物
|
US9381171B2
(en)
*
|
2013-12-19 |
2016-07-05 |
Samsung Electronics Co., Ltd. |
Composition including dapsone for preventing or treating side effect of steroid in subject and use of the composition
|
US9862704B2
(en)
*
|
2013-12-20 |
2018-01-09 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases
|
CN104744446B
(zh)
*
|
2013-12-30 |
2019-06-25 |
广东东阳光药业有限公司 |
杂芳化合物及其在药物中的应用
|
WO2015106164A1
(fr)
|
2014-01-10 |
2015-07-16 |
Rgenix, Inc. |
Agonistes du récepteur x du foie et leurs utilisations
|
US9636298B2
(en)
|
2014-01-17 |
2017-05-02 |
Methylgene Inc. |
Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
|
EP3107902B1
(fr)
|
2014-02-20 |
2021-04-07 |
Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") |
Composés et procédés d'inhibition de la fascine
|
TWI672141B
(zh)
|
2014-02-20 |
2019-09-21 |
美商醫科泰生技 |
投予ros1突變癌細胞之分子
|
ES2950384T3
(es)
|
2014-02-28 |
2023-10-09 |
Boehringer Ingelheim Int |
Uso médico de un inhibidor de DPP-4
|
US9771360B2
(en)
|
2014-03-21 |
2017-09-26 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use
|
SG10202003693RA
(en)
|
2014-05-20 |
2020-05-28 |
Millennium Pharm Inc |
Boron-containing proteasome inhibitors for use after primary cancer therapy
|
ES2749433T3
(es)
|
2014-06-23 |
2020-03-20 |
Celgene Corp |
Apremilast para el tratamiento de una enfermedad hepática o una anomalía de la función hepática
|
WO2016040190A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040185A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine et ses utilisations thérapeutiques
|
WO2016040193A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040184A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040181A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040180A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
TW201615221A
(zh)
*
|
2014-10-24 |
2016-05-01 |
朗齊生物醫學股份有限公司 |
炎症用藥臨床新應用
|
EP3215140A4
(fr)
*
|
2014-11-06 |
2018-05-02 |
The Arizona Board of Regents On Behalf of the University of Arizona |
Compositions de promédicaments à base de diazéniumdiolate pour le traitement du cancer et procédés
|
MX2017006022A
(es)
*
|
2014-11-07 |
2017-11-17 |
Univ Northwestern |
Inhibicion de ornitina aminotransferasa con analogos gaba para el tratamiento de carcinoma hepatocelular.
|
CA2969268A1
(fr)
|
2014-12-02 |
2016-06-09 |
Bayer Pharma Aktiengesellschaft |
Imidazo[1,2-a]pyridines a substitution heteroaryle et leur utilisation
|
KR102595599B1
(ko)
|
2014-12-02 |
2023-11-02 |
이그니타, 인코포레이티드 |
신경모세포종의 치료를 위한 병용
|
BR112017011764A2
(pt)
*
|
2014-12-02 |
2018-07-10 |
Kempharm, Inc. |
ácido benzóico, derivados de ácido benzóico e conjugados de ácido heteroaril carboxílico de oximorfona, pro-fármacos, métodos e preparação e uso dos mesmos
|
EP3226869A4
(fr)
*
|
2014-12-03 |
2018-07-18 |
Auckland UniServices, Ltd. |
Promédicament inhibiteur de kinase pour le traitement du cancer
|
US10278976B2
(en)
*
|
2014-12-12 |
2019-05-07 |
Mira Dx, Inc. |
Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumors
|
CN116617195A
(zh)
*
|
2015-01-22 |
2023-08-22 |
米托充制药公司 |
脑源性神经营养因子的诱导表达
|
AU2016226006B2
(en)
|
2015-03-04 |
2021-03-04 |
Vanda Pharmaceuticals Inc. |
Method of treatment with tradipitant
|
EP3274053A4
(fr)
|
2015-03-23 |
2018-12-05 |
The Brigham and Women's Hospital, Inc. |
Nanoparticules tolérogéniques pour le traitement du diabète sucré
|
SG11201708286PA
(en)
*
|
2015-04-20 |
2017-11-29 |
Epizyme Inc |
Combination therapy for treating cancer
|
PL3288933T3
(pl)
*
|
2015-04-30 |
2022-03-21 |
Musc Foundation For Research Development |
Związki oksindolowe i ich kompozycje farmaceutyczne
|
US20160324914A1
(en)
|
2015-05-05 |
2016-11-10 |
Tocol Pharmaceuticals, Llc |
Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation
|
TWI713534B
(zh)
|
2015-06-11 |
2020-12-21 |
日商第一三共股份有限公司 |
5-羥基-4-(三氟甲基)吡唑并吡啶衍生物之結晶及其用途
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
WO2017023980A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines et leurs utilisations thérapeutiques
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023993A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023987A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023975A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines et leus utilisations thérapeutiques
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023988A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
WO2017024026A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines et leurs utilisations thérapeutiques
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023972A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023989A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017024021A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
WO2017024015A1
(fr)
*
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
US9675608B2
(en)
*
|
2015-08-26 |
2017-06-13 |
Macau University Of Science And Technology |
Identification of natural small-molecules AMPK activators for treatment of cancers or multidrug-resistant cancers
|
KR102698411B1
(ko)
*
|
2015-10-08 |
2024-08-26 |
쑤저우 운씨엔 이야오 커지 요씨엔 공시 |
Wnt 신호 전달 경로 억제제 및 이의 치료적 적용
|
GB201519450D0
(en)
*
|
2015-11-03 |
2015-12-16 |
Univ Liverpool |
Novel treatment
|
WO2017079759A1
(fr)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(3h-indazol-3-yl)-1h-imidazo[4,5-c]pyridines et leurs utilisations anti-inflammatoires
|
US9549907B1
(en)
*
|
2015-11-13 |
2017-01-24 |
Sovereign Pharmaceuticals, Llc |
Immediate release oral guaifenesin solution
|
US10765665B2
(en)
*
|
2015-11-24 |
2020-09-08 |
Melin Jeffrey |
Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases
|
ES2918589T3
(es)
*
|
2015-11-25 |
2022-07-19 |
Convergene Llc |
Inhibidores de bromodomios BET bicíclicos y usos de los mismos
|
WO2017106492A1
(fr)
|
2015-12-18 |
2017-06-22 |
Ignyta, Inc. |
Combinaisons pour le traitement du cancer
|
JP2019507773A
(ja)
*
|
2016-03-09 |
2019-03-22 |
ネザーランズ トランスレーショナル リサーチ センター ビー.ブイ. |
インドールアミン2,3−ジオキシゲナーゼの阻害剤
|
EP3430004B1
(fr)
*
|
2016-03-14 |
2020-07-15 |
Pliva Hrvatska D.O.O. |
Formes solides de sels de nilotinib
|
US10064834B2
(en)
*
|
2016-05-09 |
2018-09-04 |
Texas Tech University System |
Carbidopa for the treatment of cancer
|
CN109562113A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的螺环降解决定子体
|
WO2017201712A1
(fr)
*
|
2016-05-26 |
2017-11-30 |
中国热带农业科学院热带生物技术研究所 |
Utilisation de nootkatone
|
MX2018014871A
(es)
|
2016-06-01 |
2019-11-05 |
Samumed Llc |
Proceso de preparacion de n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4, 5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida .
|
EP3251668A1
(fr)
|
2016-06-02 |
2017-12-06 |
Pharmotech SA |
Compositions de cannabidiol et leurs utilisations
|
EP4233840A3
(fr)
|
2016-06-10 |
2023-10-18 |
Boehringer Ingelheim International GmbH |
Combinaisons de linagliptine et de metformine
|
EP3509575A4
(fr)
*
|
2016-09-07 |
2020-04-22 |
Temple University Of The Commonwealth System Of Higher Education |
Compositions et méthodes de traitement de la résistance à l'insuline
|
EP3446704A1
(fr)
|
2017-08-24 |
2019-02-27 |
Isofol Medical AB |
[6r]-mthf - folate efficace en remplacement d'une chimiothérapie à base de 5-fluorouracile
|
EP3446703A1
(fr)
*
|
2017-08-24 |
2019-02-27 |
Isofol Medical AB |
Administration de bolus multiples 6r]-mthf dans une chimiothérapie à base de 5-fluorouracile
|
EP3528808B1
(fr)
|
2016-10-21 |
2021-10-06 |
BioSplice Therapeutics, Inc. |
Procédés d'utilisation d'indazole-3-carboxamides et leur utilisation en tant qu'inhibiteurs de la voie de signalisation wnt/ -caténine
|
JP2019533702A
(ja)
|
2016-11-07 |
2019-11-21 |
サミュメッド リミテッド ライアビリティ カンパニー |
単回用量の調整済み注射用製剤
|
KR20190104524A
(ko)
|
2016-11-21 |
2019-09-10 |
바이킹 테라퓨틱스 인코포레이티드 |
당원축적질환의 치료 방법
|
RU2764558C2
(ru)
|
2016-12-15 |
2022-01-18 |
Сосьете Де Продюи Нестле С.А. |
Композиции и способы, регулирующие усвояемость у животного-компаньона
|
US10723716B2
(en)
|
2016-12-21 |
2020-07-28 |
New York University |
Alpha-helix mimetics as modulators of Abeta self-assembly
|
JP7050792B2
(ja)
|
2017-01-26 |
2022-04-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベンジルオキシピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用
|
CN110198928B
(zh)
|
2017-01-26 |
2023-08-29 |
勃林格殷格翰国际有限公司 |
苄氧基吡啶基环丙烷甲酸、其药物组合物和用途
|
CN110177773B
(zh)
|
2017-01-26 |
2023-08-25 |
勃林格殷格翰国际有限公司 |
苄基氨基吡啶基环丙烷羧酸、其药物组合物及其用途
|
CN110248929B
(zh)
|
2017-01-26 |
2023-05-12 |
勃林格殷格翰国际有限公司 |
苄基氨基吡嗪基环丙烷甲酸、其药物组合物和用途
|
US10550127B1
(en)
|
2017-02-08 |
2020-02-04 |
Boehringer Ingelheim International Gmbh |
Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes
|
AU2018220861B2
(en)
|
2017-02-14 |
2021-08-19 |
Isofol Medical Ab |
Methods for increasing blood plasma 2'-deoxyuridine (dUrd) and thymidylate synthase inhibition
|
US10517842B2
(en)
*
|
2017-03-15 |
2019-12-31 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Methods of modulating miRNA levels and compositions for use in the same
|
RU2675496C1
(ru)
*
|
2017-03-31 |
2018-12-20 |
Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук |
Способ получения алкиловых эфиров гидроксибензойных кислот
|
MX2019011543A
(es)
|
2017-03-31 |
2019-12-16 |
Corcept Therapeutics Inc |
Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical.
|
US20180280319A1
(en)
*
|
2017-04-04 |
2018-10-04 |
University Of The Sciences |
Compounds and compositions for treatment of breast cancer
|
FR3066393B1
(fr)
*
|
2017-05-16 |
2019-07-19 |
Polyneuros |
Principe actif constitue par un melange de composes poly-lysine et utilisation dans la prevention des avc et le traitement de la phase inflammatoire post-avc
|
US11491150B2
(en)
|
2017-05-22 |
2022-11-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
EP3634426A4
(fr)
|
2017-06-05 |
2021-04-07 |
Viking Therapeutics, Inc. |
Compositions pour le traitement d'une fibrose
|
US10398693B2
(en)
*
|
2017-07-19 |
2019-09-03 |
Ignyta, Inc. |
Pharmaceutical compositions and dosage forms
|
US10639313B2
(en)
*
|
2017-09-01 |
2020-05-05 |
Ndsu Research Foundation |
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
|
BR112020004964A2
(pt)
|
2017-09-13 |
2020-09-15 |
Vanda Pharmaceuticals Inc. |
método que consiste em administrar uma quantidade de tradipitant eficaz, aperfeiçoamento, método aperfeiçoado para tratar um paciente que sofre de prurido ou dermatite atópica com tradipitant, e, métodos para tratar um paciente com prurido ou dermatite atópica, para selecionar e para determinar uma dosagem de tradipitant eficaz, para determinar que um paciente tem probabilidade de responder ao tratamento de dermatite atópica com tradipitant e para identificar um paciente.
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
WO2019071147A1
(fr)
|
2017-10-05 |
2019-04-11 |
Fulcrum Therapeutics, Inc. |
Inhibiteurs de la kinase p38 réduisant l'expression du gène dux4 et des gènes aval pour le traitement de la fshd
|
CN111225662B
(zh)
|
2017-10-17 |
2022-11-22 |
伊尼塔公司 |
药物组合物和剂型
|
US11607458B2
(en)
*
|
2017-10-25 |
2023-03-21 |
Georgia State University Research Foundation, Inc. |
Enrichment-triggered chemical delivery system
|
SG11202002947TA
(en)
|
2017-11-03 |
2020-04-29 |
Aclaris Therapeutics Inc |
Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same
|
WO2019104062A1
(fr)
|
2017-11-21 |
2019-05-31 |
Rgenix, Inc. |
Polymorphes et leurs utilisations
|
EA202091979A1
(ru)
|
2018-03-22 |
2021-06-22 |
Вайкинг Терапьютикс, Инк. |
Кристаллические формы и способы получения кристаллических форм соединения
|
CA3094324A1
(fr)
|
2018-03-26 |
2019-10-03 |
Clear Creek Bio, Inc. |
Compositions et procedes pour inhiber la dihydroorotate deshydrogenase
|
AU2019282047B2
(en)
|
2018-06-04 |
2022-06-02 |
Corcept Therapeutics Incorporated |
Pyrimidine cyclohexenyl glucocorticoid receptor modulators
|
EP3833350A4
(fr)
|
2018-08-10 |
2022-05-18 |
Aclaris Therapeutics, Inc. |
Inhibiteurs de pyrrolopyrimidine itk
|
US12102646B2
(en)
|
2018-12-05 |
2024-10-01 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis and inflammation
|
AU2019404026B2
(en)
|
2018-12-19 |
2023-06-08 |
Corcept Therapeutics Incorporated |
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
|
US11389432B2
(en)
|
2018-12-19 |
2022-07-19 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
US11234971B2
(en)
|
2018-12-19 |
2022-02-01 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
SG11202108927UA
(en)
|
2019-05-02 |
2021-09-29 |
Aclaris Therapeutics Inc |
Substituted pyrrolopyridines as jak inhibitors
|
UA128573C2
(uk)
|
2019-12-11 |
2024-08-14 |
Корсепт Терапьютікс Інкорпорейтед |
Способи лікування підвищення маси тіла, індукованого антипсихотичними засобами, за допомогою мірикориланту
|
ES2982346T3
(es)
|
2019-12-13 |
2024-10-15 |
Inspirna Inc |
Sales metálicas y usos de las mismas
|
US12076315B2
(en)
|
2020-03-20 |
2024-09-03 |
Clear Creek Bio, Inc. |
Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
|
JP2023524780A
(ja)
|
2020-05-06 |
2023-06-13 |
コーセプト セラピューティクス, インコーポレイテッド |
ピリミジンシクロヘキシルグルココルチコイド受容体モジュレーターの多形
|
US11071739B1
(en)
|
2020-09-29 |
2021-07-27 |
Genus Lifesciences Inc. |
Oral liquid compositions including chlorpromazine
|
US11865139B2
(en)
|
2020-11-12 |
2024-01-09 |
Thermolife International, Llc |
Method of treating migraines and headaches
|
AU2021409656A1
(en)
|
2020-12-21 |
2023-07-06 |
Corcept Therapeutics Incorporated |
Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators
|
CN113354558B
(zh)
*
|
2021-07-12 |
2022-03-11 |
无锡双启科技有限公司 |
一种2-氨基-5-氟苯腈的制备方法
|